Tag : FFRangio

CONFERENCE UPDATE

FFRangio demonstrates non-inferiority to pressure wire based physiologic assessment in intermediate coronary lesions: Results from the ALL-RISE randomized trial
The multicenter, randomized ALL-RISE trial demonstrated that angiography-derived fractional flow reserve (FFRangio)-guided revascularization for intermediate coronary lesions is non-inferior to conventional wire-based physiology. At 1 year, clinical outcomes (death, myocardial infarction, unplanned revascularization) were comparable and consistent across subgroups. Importantly, FFRangio significantly optimized procedural efficiency, reducing assessment time, fluoroscopy exposure, and overall duration.